Finland· FI-REL-REL49366
HorStem
A muut tuki- ja liikuntaelinten sairauksien lääkkeet product containing mesenchymal stem cells (mscs), registered in Finland by EquiCord S.L..
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Mesenchymal stem cells (MSCS)
- Manufacturer
- EquiCord S.L.
- Country
- Finland (FI)
- ATC code
- QM09AX
- ATC class
- MUUT TUKI- JA LIIKUNTAELINTEN SAIRAUKSIEN LÄÄKKEET
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/152ff659-e7ec-412a-b8f4-8e532924eb61 GET /v1/drugs/152ff659-e7ec-412a-b8f4-8e532924eb61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, suspensio",
"route": "Nivelen sisään",
"ddd_unit": null,
"strength": null,
"atc_label": "MUUT TUKI- JA LIIKUNTAELINTEN SAIRAUKSIEN LÄÄKKEET",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/2/18/226/001",
"fimea_rel_id": "REL49366",
"authorised_at": "2019-06-19"
}See everything about mesenchymal stem cells (mscs).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.